CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the UBS Global Life Sciences Conference on Tuesday, September 21 at 3:30 p.m. ET at The Grand Hyatt New York.
